Found: 10
Select item for more details and to access through your institution.
A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 3, p. 719, doi. 10.1007/s10549-018-05125-4
- By:
- Publication type:
- Article
Expert perspectives on biosimilar monoclonal antibodies in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 144, n. 2, p. 233, doi. 10.1007/s10549-014-2879-9
- By:
- Publication type:
- Article
Metastatic Breast Cancer: Patient Journey, Patient Needs, and Expectations: Results of the RÉALITÉS National Survey.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
- Published in:
- British Journal of Cancer, 2007, v. 96, n. 4, p. 654, doi. 10.1038/sj.bjc.6603584
- By:
- Publication type:
- Article
The taxanes: toxicity and quality of life considerations in advanced ovarian cancer.
- Published in:
- British Journal of Cancer, 2003, v. 89, p. S16, doi. 10.1038/sj.bjc.6601496
- By:
- Publication type:
- Article
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
- Published in:
- British Journal of Cancer, 2000, v. 83, n. 11, p. 1480, doi. 10.1054/bjoc.2000.1461
- By:
- Publication type:
- Article
Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agents.
- Published in:
- British Journal of Cancer, 2012, v. 106, n. 5, p. 854, doi. 10.1038/bjc.2012.10
- By:
- Publication type:
- Article
Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2.
- Published in:
- British Journal of Cancer, 2012, v. 106, n. 4, p. 673, doi. 10.1038/bjc.2011.591
- By:
- Publication type:
- Article